Machine learning can help predict whether people newly diagnosed with MS will experience disability worsening that occurs ...

Bengaluru Chapter, in collaboration with the Rotary Action Group Against Multiple Sclerosis (RAGAMS), hosted an awareness and ...

MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...

Two novel sub-types of multiple sclerosis (MS) have been identified, a discovery potentially paving the way for new treatments. Researchers employed artificial intelligence (AI) to assess brain scans ...

Exclusive: Scientists uncovered biological strands using artificial intelligence and hope discovery will revolutionise treatment Scientists have discovered two new subtypes of multiple sclerosis with ...

DMTs slow the progression of multiple sclerosis and reduce relapse severity. Starting DMTs soon after diagnosis can help ...

Explore the significant impact of obesity on multiple sclerosis (MS) progression, including increased symptoms, disability, and comorbidities. Learn how to manage weight effectively with professional ...

NICE has recommended the drug, natalizumab, as an option for adults with relapsing-remitting MS (RRMS) that remains highly active after a full course of at least one disease-modifying therapy, and for ...

In the swiftly evolving field of artificial intelligence (AI), the technology's capability to revolutionize care processes in ...

Annual out-of-pocket costs for multiple sclerosis (MS) care in the US increased by 125% from 2002 to 2021, primarily driven by newer disease-modifying therapies (DMTs), a new study showed. Researchers ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...